Echelon Wealth Partners Releases a Buy Rating on CloudMD Software & Services (DOCRF)

In a report issued on January 12, Rob Goff from Echelon Wealth Partners assigned a Buy rating to CloudMD Software & Services (DOCRFResearch Report), with a price target of C$3.25. The company’s shares closed last Tuesday at $1.79.

Goff has an average return of 89.0% when recommending CloudMD Software & Services.

According to TipRanks.com, Goff is ranked #56 out of 7243 analysts.

CloudMD Software & Services has an analyst consensus of Strong Buy, with a price target consensus of $2.65.

See today’s analyst top recommended stocks >>

Based on CloudMD Software & Services’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $3.36 million and GAAP net loss of $2.72 million. In comparison, last year the company earned revenue of $2.17 million and had a GAAP net loss of $809.7K.

Based on the recent corporate insider activity of 20 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of DOCRF in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Premier Health Group Inc. is a Canadian company. It is focused on health care approaches that combine human skill-based expertise with emerging technologies. The firm along with its subsidiary offers SAAS based health technology solutions including a cloud-based Electronic Medical Records (EMR) software, medical billing software and an online patient portal, Premier Health Group is also developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI).